OnKure Therapeutics, Inc. (OKUR)
Healthcare
Biotechnology
3.80 $
-4.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns OnKure Therapeutics, Inc. (OKUR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 43.3% of the shares are freely tradable; institutional investors hold 76.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
76.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
10.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
43.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
0.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
40Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 9.90 | 3,998,333 | +0.0 | 03/31/2026 |
| StepStone Group LLC | 6.59 | 2,660,612 | +440.8 | 03/31/2026 |
| ADAR1 Capital Management LLC | 6.03 | 2,434,941 | +140.1 | 03/31/2026 |
| Prosight Management, LP | 5.33 | 2,154,381 | +163.7 | 03/31/2026 |
| Bvf Inc | 4.90 | 1,978,972 | +0.0 | 03/31/2026 |
| Vivo Capital, LLC | 4.77 | 1,927,710 | +0.0 | 03/31/2026 |
| Vestal Point Capital LP | 4.55 | 1,839,819 | +189.7 | 03/31/2026 |
| Foresite Capital Management VI LLC | 3.58 | 1,445,783 | +0.0 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 2.98 | 1,204,819 | +0.0 | 03/31/2026 |
| Sio Capital Management, LLC | 2.67 | 1,078,965 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.